89 related articles for article (PubMed ID: 16901688)
1. Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical modelling.
Modok S; Hyde P; Mellor HR; Roose T; Callaghan R
Eur J Cancer; 2006 Sep; 42(14):2404-13. PubMed ID: 16901688
[TBL] [Abstract][Full Text] [Related]
2. Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle targeting.
Gonzalez-Alvarez I; Gonzalez-Alvarez M; Oltra-Noguera D; Merino V; Tõkési N; Ovádi J; Bermejo M
Eur J Pharm Sci; 2009 Jan; 36(1):11-9. PubMed ID: 19028571
[TBL] [Abstract][Full Text] [Related]
3. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model.
Modok S; Scott R; Alderden RA; Hall MD; Mellor HR; Bohic S; Roose T; Hambley TW; Callaghan R
Br J Cancer; 2007 Jul; 97(2):194-200. PubMed ID: 17579620
[TBL] [Abstract][Full Text] [Related]
4. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
5. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
8. Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
Ravizza R; Molteni R; Gariboldi MB; Marras E; Perletti G; Monti E
Eur J Cancer; 2009 Mar; 45(5):890-8. PubMed ID: 19171477
[TBL] [Abstract][Full Text] [Related]
9. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
10. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
[TBL] [Abstract][Full Text] [Related]
11. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
[TBL] [Abstract][Full Text] [Related]
12. Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.
Hicks KO; Pruijn FB; Sturman JR; Denny WA; Wilson WR
Cancer Res; 2003 Sep; 63(18):5970-7. PubMed ID: 14522924
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation at the leading invasive front of colonic carcinomas. Preliminary observations.
Rubio CA
Anticancer Res; 2006; 26(3B):2275-8. PubMed ID: 16821601
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line.
Klamt F; Passos DT; Castro MA; Gelain DP; Grivicich I; Moreira JC
Toxicol In Vitro; 2008 Jun; 22(4):873-8. PubMed ID: 18282684
[TBL] [Abstract][Full Text] [Related]
15. Effect of heterogeneous vasculature on interstitial transport within a solid tumor.
Zhao J; Salmon H; Sarntinoranont M
Microvasc Res; 2007 May; 73(3):224-36. PubMed ID: 17307203
[TBL] [Abstract][Full Text] [Related]
16. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
Hamad I; Moghimi SM
Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
[TBL] [Abstract][Full Text] [Related]
17. Extravascular transport of drugs in tumor tissue: effect of lipophilicity on diffusion of tirapazamine analogues in multicellular layer cultures.
Pruijn FB; Sturman JR; Liyanage HD; Hicks KO; Hay MP; Wilson WR
J Med Chem; 2005 Feb; 48(4):1079-87. PubMed ID: 15715475
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced myelosuppression by vinorelbine: a comparison between different dose schedules by simulation.
Urso R; Nencini C; Giorgi G; Fiaschi AI
Eur Rev Med Pharmacol Sci; 2007; 11(6):413-7. PubMed ID: 18306910
[TBL] [Abstract][Full Text] [Related]
19. External magnet improves antitumor effect of vinblastine and the suppression of metastasis.
Dandamudi S; Patil V; Fowle W; Khaw BA; Campbell RB
Cancer Sci; 2009 Aug; 100(8):1537-43. PubMed ID: 19459849
[TBL] [Abstract][Full Text] [Related]
20. Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells.
Visentin M; Simula MP; Sartor F; Petrucco A; De Re V; Toffoli G
Int J Oncol; 2009 May; 34(5):1281-9. PubMed ID: 19360340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]